Open original FDA record ↗Recall record
- FDA identifier
- Z-2176-2010
- Company in FDA record
- Ikaria Holdings
- FDA classification date
- Aug 13, 2010
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 20, 2026
- Recall classification
- Unknown — no matched enforcement classification
Reason stated in the source
The pressure switch in the INOMAX DS drug-delivery system may fail, which may interrupt or delay the administration of INOMAX (nitric oxide) for inhalation to patients. Delay in administration of INOMAX therapy may cause: -worsening of systemic oxygenation indices (i.e., hypoxemia, especially manifested as decreased arterial oxygenation saturation). -hypotension, and/or -increase in pulm
Source facts
- Action
- Ikaria sent an Urgent Medical Device Recall letter to customers dated July 21, 2010. This letter is also posted on the Inomax webpage. The letter described the issue, how to recognize it, what to do in the event of a suspected leak, and recommended maintaining back-up cylinders and depressurization of the regulator when not in use. The replacement plan for all INOMAX DS drug-delivery systems was described. Customers can contact Ikaria Customer Care at 1-877-566-9466.
- Initiated
- 2010-07-21
- Root cause
- Component design/selection
- Terminated
- 2011-12-27
- Distribution
- Worldwide Distribution to include: US Nationwide and Countries of Canada and Malaysia
- Recall number
- Z-2176-2010
- Recall status
- Terminated
- CDRH record ID
- 93145
- FDA classified
- 2010-08-13
- Recall event number
- 56290